Search research articles
Contact Us
Filters
Showing results (21-30 of 141) with videos related to
Page
of 15
Sort By:
Leukemia
|
January 12, 2026
Modeling donor age and type trade-offs for personalized selection in allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide prophylaxis
Rohtesh S Mehta, Yosra M Aljawai, Partow Kebriaei, et al.
Stem Cells Translational Medicine
|
November 8, 2014
Concise review: umbilical cord blood transplantation: past, present, and future
Javier Munoz, Nina Shah, Katayoun Rezvani, et al.
Blood Advances
|
June 15, 2025
Outcomes of haploidentical vs mismatched unrelated donor HCT with posttransplant cyclophosphamide prophylaxis
Yosra M Aljawai, Jeremy Ramdial, Gabriela Rondon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 27, 2014
Can a female donor for a male recipient decrease the relapse rate for patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation?
Piyanuch Kongtim, Antonio Di Stasi, Gabriela Rondon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 27, 2007
Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment
Betul Oran, Michele Donato, Ana Aleman, et al.
JCO Oncology Practice
|
January 13, 2026
Re-Evaluating Donor Selection Priorities for Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide
Rohtesh S Mehta, Yosra M Aljawai, Partow Kebriaei, et al.
American Journal of Hematology
|
May 12, 2017
Minimal residual disease eradication with epigenetic therapy in core binding factor acute myeloid leukemia
Brittany Knick Ragon, Naval Daver, Guillermo Garcia-Manero, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 12, 2018
Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid Leukemia
Lauren Veltri, Katayoun Rezvani, Betul Oran, et al.
NPJ Digital Medicine
|
March 2, 2026
Development and explainable AI-driven characterization of a prognostic model for haploidentical transplantation outcomes
Rohtesh S Mehta, Yosra M Aljawai, Partow Kebriaei, et al.
American Journal of Hematology
|
February 3, 2023
Younger haploidentical donor versus older matched unrelated donor for patients with AML/MDS
Curtis Marcoux, David Marin, Jeremy Ramdial, et al.
Page
of 15
Search research articles
Search
Showing results (21-30 of 141) with videos related to
Sort By:
Page
of 15
Leukemia
|
January 12, 2026
Modeling donor age and type trade-offs for personalized selection in allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide prophylaxis
Rohtesh S Mehta, Yosra M Aljawai, Partow Kebriaei, et al.
Stem Cells Translational Medicine
|
November 8, 2014
Concise review: umbilical cord blood transplantation: past, present, and future
Javier Munoz, Nina Shah, Katayoun Rezvani, et al.
Blood Advances
|
June 15, 2025
Outcomes of haploidentical vs mismatched unrelated donor HCT with posttransplant cyclophosphamide prophylaxis
Yosra M Aljawai, Jeremy Ramdial, Gabriela Rondon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 27, 2014
Can a female donor for a male recipient decrease the relapse rate for patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation?
Piyanuch Kongtim, Antonio Di Stasi, Gabriela Rondon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 27, 2007
Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment
Betul Oran, Michele Donato, Ana Aleman, et al.
JCO Oncology Practice
|
January 13, 2026
Re-Evaluating Donor Selection Priorities for Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide
Rohtesh S Mehta, Yosra M Aljawai, Partow Kebriaei, et al.
American Journal of Hematology
|
May 12, 2017
Minimal residual disease eradication with epigenetic therapy in core binding factor acute myeloid leukemia
Brittany Knick Ragon, Naval Daver, Guillermo Garcia-Manero, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 12, 2018
Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid Leukemia
Lauren Veltri, Katayoun Rezvani, Betul Oran, et al.
NPJ Digital Medicine
|
March 2, 2026
Development and explainable AI-driven characterization of a prognostic model for haploidentical transplantation outcomes
Rohtesh S Mehta, Yosra M Aljawai, Partow Kebriaei, et al.
American Journal of Hematology
|
February 3, 2023
Younger haploidentical donor versus older matched unrelated donor for patients with AML/MDS
Curtis Marcoux, David Marin, Jeremy Ramdial, et al.
Page
of 15